MedPath

Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge

Conditions
Pulmonary Rehabilitation
COVID-2019 Pneumonia
Interventions
Behavioral: Remote pulmonary rehabilitation
Registration Number
NCT04368793
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

The noval coronavirus disease 2019 (COVID-19) would cause physical and psychological dysfunctions in infected patients. We expect that an intelligence-based remote pulmonary rehabilitation scheme could improve patients' health status after hospital discharge. The intelligence-based remote pulmonary rehabilitation program is designed in a real-world and prospective manner, aiming to evaluate the efficacy of rehabilitation among 200 patients in the epicenter of China (Wuhan City) according to their varied adherence. An eight-week rehabilitation scheme, including two weeks for physicians and physiotherapists remotely guided training, and six weeks for patient self-management, will be addressed. The primary outcome of current study is six-minute walking distance and lung function, and secondly respiratory muscle strength, physical fitness assessment, symptoms and quality of life, etc. will also be assessed. Recruited patients will be followed up at week 2, 4, 8 after enrollment and at month 1, 3, 6, 12 after the rehabilitation training completed, respectively. The study has been approved by the ethics committee of China-Japan Friendship Hospital and three participating centers in Wuhan City.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Discharged COVID-19 patient cohortRemote pulmonary rehabilitationAll enrolled participants will be given 8 weeks (online 2 weeks + offline 6 weeks) pulmonary rehabilitation intervention, and will be followed up for at least one year, to assess their adherence and efficacy of the rehabilitation program.
Primary Outcome Measures
NameTimeMethod
Six-minute walking distance (6MWD)One year

Walking distance within six minutes

Pulmonary functionOne year

Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), etc.

Secondary Outcome Measures
NameTimeMethod
Respiratory muscle strengthOne year

Maximal inspiratory pressure, maximal expiratory pressure, etc.

Quality of lifeOne year

36-item short-form health survey (SF-36), etc.

SymptomOne year

Modified British Medical Research Council (mMRC) dyspnea scale, etc.

Physical activityOne year

International physical activity questionnaire (IPAQ)

Proportion of returning to societyOne year

Proportions of returning to routine work and normal life

Physical fitness assessmentOne year

Two-minute walking test, short physical performance battery, grip strength of both upper limbs, knee extension strength of both lower limbs, etc.

Psychological evaluationOne year

Self-training depression scale (SDS) and self-rating anxiety scale (SAS)

Trial Locations

Locations (3)

Wuhan Lung Hospital

🇨🇳

Wuhan, Hubei, China

Wuhan Central Hospital

🇨🇳

Wuhan, Hubei, China

Zhongnan Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath